Catalyst Wire Dossier Catalyst Wire Dossier

Ocugen RP product (Expanded Access Program)

· Ocugen, Inc.
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Ocugen RP product (Expanded Access Program), covering 2026-04-13 to 2026-04-13. Get the full timeline:

Most recent: Clinical Trial Update: Expanded Access Program for RP in Adults

See pricing